Microbiology News and Research RSS Feed - Microbiology News and Research

Researchers develop new method for identifying DNA mutations in single cancer cell

Researchers develop new method for identifying DNA mutations in single cancer cell

Researchers at The University of Texas MD Anderson Cancer Center have announced a new method for detecting DNA mutations in a single cancer cell versus current technology that analyzes millions of cells which they believe could have important applications for cancer diagnosis and treatment. The results are published in the April 18 online issue of Nature Methods. [More]
Sugar compounds provide nutrient support for growth of infant gut microbes

Sugar compounds provide nutrient support for growth of infant gut microbes

UC Davis researchers have shown that an enzyme produced by beneficial microbes in babies' intestines is able to harvest specific sugar compounds from human breast-milk and cow's milk. The discovery identifies those sugars -- rather than associated protein compounds -- as the key to nourishing those important, health-promoting microbes. [More]
Researchers reveal how relatively unknown pathogen led to current Zika outbreak

Researchers reveal how relatively unknown pathogen led to current Zika outbreak

An analysis comparing the individual differences between over 40 strains of Zika virus (30 isolated from humans, 10 from mosquitoes, and 1 from monkeys) has identified significant changes in both amino acid and nucleotide sequences during the past half-century. [More]
Scientists identify human protein that weakens immune response to HIV, other viruses

Scientists identify human protein that weakens immune response to HIV, other viruses

Scientists at the University of North Carolina School of Medicine and Sanford Burnham Prebys Medical Discovery Institute have identified a human (host) protein that weakens the immune response to HIV and other viruses. The findings, published today in Cell Host & Microbe, have important implications for improving HIV antiviral therapies, creating effective viral vaccines, and advance a new approach to treat cancer. [More]
Deadly ‘Crypto’ pathogen lures US researcher to UQ

Deadly ‘Crypto’ pathogen lures US researcher to UQ

Cryptococcus is so forsaken by research that it doesn’t even make the neglected diseases list – but the deadly fungal pathogen has lured an American scientist all the way to The University of Queensland. [More]
Studies offer alternative conclusions on efficacy of DAAs for HIV and HCV co-infected patients

Studies offer alternative conclusions on efficacy of DAAs for HIV and HCV co-infected patients

Two separate studies presented today at The International Liver Congress 2016 in Barcelona, Spain have offered alternative conclusions regarding the efficacy of direct-acting antivirals (DAAs) among patients co-infected with HIV and Hepatitis C virus (HCV). [More]
New clinical data highlights potential of AB-PA01 to treat P. aeruginosa infections in CF patients

New clinical data highlights potential of AB-PA01 to treat P. aeruginosa infections in CF patients

AmpliPhi Biosciences Corporation, a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, presented data at the European Congress of Clinical Microbiology and Infectious Diseases summarizing both the in vitro and in vivo activity of its proprietary, investigational phage mix AB-PA01. [More]
Researchers observe increase in antibiotic resistance genes

Researchers observe increase in antibiotic resistance genes

Around the world, antibiotic use and resistance is increasing while the discovery of new antibiotics has nearly halted. [More]
Novel antibiotics to overcome antibacterial resistance

Novel antibiotics to overcome antibacterial resistance

Small and innovative pharmaceutical companies, with products in early stages of development, presented some of their novel approaches and antimicrobial therapies under development during a dedicated session at the annual congress (ECCMID) of the European Society of Clinical Microbiology and Infectious Diseases(ESCMID) in Amsterdam. [More]
Dual-acting hybrid drug could be a promising new weapon against drug-resistant malaria

Dual-acting hybrid drug could be a promising new weapon against drug-resistant malaria

A combination of artemisinin and another drug (artemisinin combination therapy, ACT) is currently the best malaria treatment recommended by the World Health Organization. [More]
Cell-signaling protein holds key to understanding autoantibody formation in lupus patients

Cell-signaling protein holds key to understanding autoantibody formation in lupus patients

A signaling molecule called interferon gamma could hold the key to understanding how harmful autoantibodies form in lupus patients. The finding could lead to new treatments for the chronic autoimmune disease, said researchers at Penn State College of Medicine. [More]
Researchers analyze post-Ebola syndrome survivors to improve ongoing treatment

Researchers analyze post-Ebola syndrome survivors to improve ongoing treatment

Researchers from the University of Liverpool and the King's Sierra Leone Partnership are to present new findings into post-Ebola syndrome at a major European conference this week. [More]

ECCMID 2016: Global experts join to fight antimicrobial resistance

Medical professionals, business and government officials from around the world joined in Amsterdam on the sidelines of the ECCMID 2016 Conference, hosted by the European Society of Clinical Microbiology and Infectious Diseases to declare their commitment to fight antimicrobial resistance (AMR) in a concerted effort. [More]
New data from studies evaluating diagnostic tools, therapies for infectious diseases released at ECCMID 2016

New data from studies evaluating diagnostic tools, therapies for infectious diseases released at ECCMID 2016

New data from ten late-breaking abstracts is released at ECCMID 2016 – the annual meeting of the European Society of Clinical Microbiology and Infectious Disease. [More]
Cornell researchers discover potential way to penetrate blood brain barrier

Cornell researchers discover potential way to penetrate blood brain barrier

Cornell researchers have discovered a way to penetrate the blood brain barrier (BBB) that may soon permit delivery of drugs directly into the brain to treat disorders such as Alzheimer's disease and chemotherapy-resistant cancers. [More]
Researchers identify influenza D antibodies in small ruminants

Researchers identify influenza D antibodies in small ruminants

Although a new influenza virus, now called influenza D, was discovered first in pigs, researchers found it was more common in cattle. However, further research has identified antibodies to the virus in small ruminants, but not in poultry. [More]
Keynotes announced for ECCMID 2016

Keynotes announced for ECCMID 2016

The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) previews some of the keynote lectures at the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). The globe’s most prominent infection specialists will be gathering at its annual congress in Amsterdam from 9 – 12 April 2016. [More]
New study demonstrates diversity, resourcefulness of Vibrio cholera

New study demonstrates diversity, resourcefulness of Vibrio cholera

In humans, cholera is among the world's most deadly diseases, killing as many as 140,000 persons a year, according to World Health Organization statistics. But in aquatic environments far away from humans, the same bacterium attacks neighboring microbes with a toxic spear - and often steals DNA from other microorganisms to expand its own capabilities. [More]
Scientists find new way to inhibit growth of tuberculosis-causing bacterium

Scientists find new way to inhibit growth of tuberculosis-causing bacterium

Scientists at the The University of Queensland and the University of California San Francisco have found a new way to inhibit the growth of the bacterium that causes tuberculosis (TB). [More]
Researchers develop mouse model for testing vaccines, therapeutics to battle Zika virus

Researchers develop mouse model for testing vaccines, therapeutics to battle Zika virus

A research team at Washington University School of Medicine in St. Louis has established a mouse model for testing of vaccines and therapeutics to battle Zika virus. [More]
Advertisement
Advertisement